
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
A study has found that guggul, a popular folk remedy made from a tree resin, may be detrimental to people's cholesterol levels - despite laboratory experiments suggesting otherwise.